|
News
-
03.06.2024Perkins Coie Advises Attune Medical in Acquisition by HaemoneticsPress ReleasesPerkins Coie is pleased to have advised Chicago-based Attune Medical in its definitive acquisition agreement with Haemonetics Corporation, a global medical technology company focused on delivering innovative medical products and solutions.
-
12.14.2023Perkins Coie Represents TRACT Therapeutics in Strategic Collaboration with Taiwan BioPress ReleasesPerkins Coie is pleased to have represented TRACT Therapeutics, a clinical stage biotechnology company, in its strategic collaboration deal to advance cellular therapy with Taiwan Bio, a one-stop, total solution cell therapy contract development and manufacturing organization.
-
01.09.2014Perkins Coie Represents Chromatin in $36 Million FinancingPress ReleasesPerkins Coie represented client Chromatin, Inc., an agriculture technology company that develops sorghum for both traditional agriculture markets and for uses in new applications, in the closing of a $36 million Series E financing. The funding will support additional expansion and accelerate product development and differentiation for sales in both the U.S. and international markets.
